Display options
Cite
Nilsson G, Wang M, Wejde J, et al. Detection of EWS/FLI-1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing's Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin-Embedded Archival Material. Sarcoma. 1999;3(1):25-32doi: 10.1080/13577149977839.
Nilsson, G., Wang, M., Wejde, J., Kreicbergs, A., & Larsson, O. (1999). Detection of EWS/FLI-1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing's Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin-Embedded Archival Material. Sarcoma, 3(1), 25-32. https://doi.org/10.1080/13577149977839
Nilsson, G, et al. "Detection of EWS/FLI-1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing's Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin-Embedded Archival Material." Sarcoma vol. 3,1 (1999): 25-32. doi: https://doi.org/10.1080/13577149977839
Nilsson G, Wang M, Wejde J, Kreicbergs A, Larsson O. Detection of EWS/FLI-1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing's Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin-Embedded Archival Material. Sarcoma. 1999;3(1):25-32. doi: 10.1080/13577149977839. PMID: 18521261; PMCID: PMC2395406.
Copy Download .nbib Format: NLM
Share it on

Sarcoma. 1999;3(1):25-32. doi: 10.1080/13577149977839.

Detection of EWS/FLI-1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing's Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin-Embedded Archival Material.

Sarcoma

G Nilsson, M Wang, J Wejde, A Kreicbergs, O Larsson

Affiliations

  1. Department of Cellular and Molecular Tumour Pathology Cancer Center Karolinska Karolinska Hospital Stockholm S-17176 Sweden.

PMID: 18521261 PMCID: PMC2395406 DOI: 10.1080/13577149977839

Abstract

Purpose. Recently we showed that the 68-kDa fusion protein derived from the EWS/FLI1 hybrid gene can be specifically detected by Western blotting using a polyclonal antibody to the C-terminal of FLI1 on biopsy material from Ewing's sarcoma. The aim of this study was to investigate whether this antibody also could be used for immunocytochemistry and immunohistochemistry in diagnosis of Ewing's sarcoma.Methods. Immunostaining on paraffin-embedded archival material, fine-needle aspirates and tumour touch imprints from Ewing's sarcomas and primitive neuroectodermal tumours (PNET) for detection of the fusion protein was performed. Most cases were also analysed by Western blotting.Tumours of differential diagnostic importance were also included.Results. Eighty per cent (12/15 cases) of the Ewing tumours exhibited a positive immunoreactivity for the FLI1 antibody. The signal was mainly localised in the nuclei of the tumour cells, which seems reasonable since EWS/FLI1 is a transcription factor. The signal was found to be specific since it did not appear when the blocking peptide was added to the antibody solution.Moreover, two other types of small-round cell tumours (i.e. neuroblastoma and alveolar rhabdomyosarcoma) were negative as well as most normal tissues.Discussion. Immunostaining of histological and cytological specimens with the FLI1 antibody can be of diagnostic relevance in Ewing tumours carrying t(11;22).The absence of immunoreactivity in non-Ewing cells is most likely due to a low expression of the wild-type FLI1 protein.

References

  1. Genes Chromosomes Cancer. 1992 Nov;5(4):271-7 - PubMed
  2. Ultrastruct Pathol. 1996 Nov-Dec;20(6):507-17 - PubMed
  3. Sarcoma. 1998;2(1):3-17 - PubMed
  4. Am J Surg Pathol. 1994 May;18(5):486-94 - PubMed
  5. Hum Pathol. 1984 Jun;15(6):575-84 - PubMed
  6. Mod Pathol. 1992 Jan;5(1):71-8 - PubMed
  7. Cancer Genet Cytogenet. 1997 Aug;97(1):12-9 - PubMed
  8. Eur J Biochem. 1993 Jan 15;211(1-2):7-18 - PubMed
  9. Genes Dev. 1992 Mar;6(3):481-96 - PubMed
  10. Hum Pathol. 1994 Mar;25(3):304-7 - PubMed
  11. Cancer Invest. 1990;8(6):629-39 - PubMed
  12. Biochim Biophys Acta. 1993 Feb 20;1172(1-2):155-8 - PubMed
  13. Cancer Res. 1993 Dec 15;53(24):5859-63 - PubMed
  14. Oncogene. 1997 Mar 13;14(10):1159-64 - PubMed
  15. Cancer Genet Cytogenet. 1988 Jun;32(2):229-38 - PubMed
  16. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  17. Nat Genet. 1994 Feb;6(2):146-51 - PubMed
  18. Hybridoma. 1997 Oct;16(5):457-64 - PubMed
  19. Pediatr Pathol. 1990;10(1-2):175-93 - PubMed
  20. Oncogene. 1995 Mar 16;10(6):1229-34 - PubMed
  21. Lab Invest. 1992 Feb;66(2):133-7 - PubMed
  22. Am J Pathol. 1993 Nov;143(5):1294-300 - PubMed
  23. Virchows Arch. 1994;425(2):107-12 - PubMed
  24. Anal Biochem. 1976 May 7;72:248-54 - PubMed
  25. Virchows Arch. 1998 Feb;432(2):131-4 - PubMed
  26. N Engl J Med. 1994 Aug 4;331(5):294-9 - PubMed

Publication Types